
Inflamend is a dietary supplement designed for men suffering from all forms of prostatitis. Contains 2 types of tablets (yellow and blue), each of which is enriched with an additional ingredient:
- The blue tablets contain silver nanoparticles with antibacterial and anti-inflammatory action.
- Yellow tablets contain a powerful probiotic strain with immunostimulating effect.
INFLAMEND for prostatitis Act:
Infland action actively cross prostatitis through 4 mechanisms:
- destroys pathogenic microorganisms through the silver nanoparticles in its composition. Due to their extremely small size, they penetrate freely into the prostate tissue, where they actively destroy the causes of infection.
- relaxes the smooth muscles of the prostate and reduces tension, pain and a feeling of heaviness in the pelvic floor.
- Stops inflammation and relieves symptoms by suppressing the secretion of substances that cause inflammation in the prostate.
- stimulates the immune system and strengthens the local immunity in the genitourinary tract.
INFLAMEND for prostatitis Composition:
1 yellow tablet contains: standardized Pygeum africanum extract 50mg, standardized pollen extract Graminex G63 125mg, Lactobacillus acidophilus LA11 (5 billion live cells) 50mg.
1 blue tablet contains: silver nanoparticles 25ng, standardized extract of Pygeum africanum 50mg, standardized pollen extract Graminex G63 125mg.
The standardized pollen extract Graminex G63 has a reduced risk of allergic reactions, thanks to the special technology of its preparation, which eliminates allergens from the pollen shell.
INFLAMEND for prostatitis Dosage:
For prostatitis and urethritis, take 1 yellow tablet in the morning and 1 blue tablet in the evening for 90 days.
Do not take Inflamend if you have ever had an allergic reaction to any of the ingredients.
Do not take by pregnant and lactating women and children.
So far, no side effects and contraindications are known.
Inflamend can be taken alone or in combination with another product, after consultation with your doctor.